| Characteristic | Penalties in million U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
March 2016
Region
United States
Survey time period
July 19, 2012 to December 31, 2015
Supplementary notes
* From settlements between state and federal governments and pharmaceutical manufacturers. Listed are parent companies at time of settlement.
Citation formats









